No Additional Benefit of CBT in Treating Opioid Addiction with Buprenorphine

The addition of cognitive behavioral therapy (CBT) to medical treatment for opioid dependence does not significantly enhance outcomes compared with medical treatment alone, new research shows. The study, published in the January issue of the American Journal of Medicine, involved 141 opioid-dependent patients recruited from a primary care clinic who were being treated with buprenorphine.

David Fiellin, MD, and colleagues from the Yale University School of Medicine, New Haven, Connecticut, found that CBT provided by trained clinicians did not improve abstinence from opioid use or retention rates in treatment programs when added to physician management alone.

On January 23, 2013 the full article was available for free to view online at:

Source: Medscape Medical News – January 10, 2013